THERAPEUTICS OF DIABETIC MACULAR EDEMA THROUGH THE LENS OF AYURVEDA: A CASE REPORT
Main Article Content
Keywords
Ayurvedic management, Diabetic macular edema, Prameha janya timir
Abstract
Abstract: Prevalence of Diabetes Mellitus (DM) has increased drastically. Diabetic Retinopathy (DR) is associated complication which causes vision loss. Vascular leakage leads to fluid built up in macular region of retina causing Diabetic Macular Edema. Diabetic Macular Edema (DME) is a dreadful complication of Diabetic Retinopathy. According to ayurveda, tridosha along with rakta, sapta dhatu in association with drishtigata patala are involved in manifestation of prameha janya timira. current management approaches for ayurvedic treatment modalities for Diabetic Macular Edema.
Objective: To rescue patient's vision and provide symptomatic relief by ayurvedic management in diabetic macular edema.
Material and Method: 63 year old male patient, visited shalakyatantra OPD on 8th may 2018, with diminished vision, black spots in front of left eye since 13 days, known systemic history of diabetes mellitus since 11 years was diagnosed as prameha janya timira and treated accordingly. Result: Blood sugar level was reduced and controlled. Marked symptomatic relief on subjective as well as objective parameters were noted.
Discussion: Ayurvedic management in Diabetic Macular Edema offers a promising alternative for significant relief in symptoms, visual improvement and to slow down the disease advancement
References
2. Oshitari T. The pathogenesis and therapeutic approaches of diabetic neuropathy in the retina. Int J Mol Sci (2021) 22:9050. Doi: 10.3390/ijms22169050
3. A K Khurana, comprehensive ophthalmology, 5th edition. New age international (P) ltd. Reprint 2014 P-275.
4. Paradakara HS. Astanga hridaya of vagbhatta, uttarsthana. 9th Ed. Ch.12 vers 10 Varanasi: Chaukhamba Orientalia publication; 2010 P. 817,157.
5. Shanti, K., & Remya, R. S. (2022). Ayurvedic Management of Diabetic Macular Oedema — DME — A Case Report. Journal of Natural Remedies, 22(3), 363–370. https://doi.org/10.18311/jnr/2022/28782
6. Shastri A Editor, Hindi commentary ayurveda tattva sandipika, sushruta samhita uttar tantra, drishtirogavigyaniya,Varanasi: Chaukhamba Orientalia publication; 2016 P 41.
7. Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME. Vascular endothelial growth factor in eye disease. Prog Retin Eye Res (2008) 27:331–71. Doi: 10.1016/j.preteyeres.2008.05.001
8. Harishastri P, editor. Ashtanga Hridayam of Vagbhata, Kalpasiddhi Sthana. Reprint 10th Edition. Varanasi: Chowkhamba Surabharati Prakashan; 2011. P. 743. Ch. 2, Ver. 21-23.
9. Krishnan V, Pillai G, editors. Sahasrayoga, Ghrita Yoga. 26th ed. Kerala: Vidyarambham Publishers; 2006. P. 337.
10. Krishnan V, Pillai G, editors. Sahasrayoga, Sudhikrama. 26th ed. Kerala: Vidyarambham Publishers; 2006. P. 475.
11. Lu K, Chakroborty D, Sarkar C, Lu T, Xie Z, Liu Z, et al. Triphala and its active constituent chebulinic acid are natural inhibitors of vascular endothelial growth factor – A mediated angiogenesis. PLoS One. 2012;7:e43934.